All Stories

  1. Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer
  2. A Phospholipase-A Activity in Soluble Leishmania Antigens Causes Instability of Liposomes
  3. P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer
  4. miR-155 influences cell-mediated immunity in Balb/c mice treated with aflatoxin M1
  5. Enhancement of the effect of BCG vaccine against tuberculosis using DDA/TDB liposomes containing a fusion protein of HspX, PPE44, and EsxV
  6. Preparation of nanoliposomes linked to HER2/neu-derived (P5) peptide containing MPL adjuvant as vaccine against breast cancer
  7. Immunotoxicity of aflatoxin M1 : as a potent suppressor of innate and acquired immune systems in a subacute study
  8. The role of LPD-nanoparticles containing recombinant major surface glycoprotein of Leishmania (rgp63) in protection against leishmaniasis in murine model
  9. PEGylation of cationic liposomes encapsulating soluble Leishmania antigens reduces the adjuvant efficacy of liposomes in murine model
  10. Liposomal adjuvant development for leishmaniasis vaccines